Table 1:

Laboratory investigations of a 22-year-old man with severe aortoiliac occlusive disease

TestResult (reference range)
Hematology and coagulation
 Hemoglobin, g/L137 (137–180)
 Leukocyte count, × 109/L7.1 (4.0–11.0)
 Platelet count, × 109/L394 (150–400)
 Prothrombin time and international normalized ratio1.3
 Partial thromboplastin time, s61.4 (28.0–38.0)
 Direct antiglobulin testPositive, IgG and complement components detected
 Haptoglobin, g/L1.01 (0.30–2.00)
 Reticulocyte count, × 109/L58.5 (20–100)
Biochemistry
 Creatinine, μmol/L62 (50–120)
 UrinalysisBland
 Urine protein:creatinine, g/mmol0.005 (≤ 0.013)
 C-reactive protein, mg/L8.4 (< 5)
 Alanine aminotransferase, U/L23 (< 6)
 Albumin, g/L34 (33–48)
 Total bilirubin, μmol/L9 (< 21)
 Lactate dehydrogenase, U/L195 (135–225)
 Low-density lipoprotein, mmol/L2.71 (0.00–3.40)
Serology and immunology
 Antinuclear antibody≥ 1:640 speckled (≤ 1:80)
 Extractable nuclear antigen panel
  Antichromatin, AI3.5 (≤ 0.9)
  Anti-Smith, AI4.2 (≤ 0.9)
  Anti-U1 small nuclear ribonucleoprotein A, AI1.8 (≤ 0.9)
 Anti-double-stranded DNA, kIU/L944 (0–9)
 C3, g/L0.91 (0.60–1.60)
 C4, g/L0.05 (0.10–0.40)
 Lupus anticoagulantPresent
 Anticardiolipin IgG, GPUHigh positive, > 160.0 (0.0–19.9)
 Anti-β2 glycoprotein-1 IgG, GPUHigh positive, > 160.0 (0.0–19.9)
  • Note: AI = antibody index, GPU = immunoglobulin G phospholipid units, Ig = immunoglobulin.